Study: Men face 3x higher ICU risk, 40% greater death risk from COVID-19

A sweeping analysis of data from more than three million confirmed COVID-19 cases across 46 countries has surfaced a stark biological pattern: men who contract the virus face nearly triple the risk of requiring intensive care and carry a 40 percent higher likelihood of death compared to women. The finding, published in Nature Communications in December 2020, emerged from researchers combing through 90 separate studies tracking infection, hospitalization, and mortality across the globe, including data from 44 U.S. states.

What makes the discovery particularly striking is what it does not show. Men and women, the data revealed, have essentially equal odds of becoming infected with the coronavirus in the first place. The divergence happens after infection takes hold. In the eight studies that specifically tracked ICU admissions, men accounted for nearly 70 percent of those cases. Among the 70 studies reporting death outcomes, men represented roughly 56 percent of the more than 214,000 documented deaths analyzed.

Dr. Kate Webb, a pediatric rheumatologist at the University of Cape Town and one of the study's lead authors, was careful to frame the findings not as cause for alarm but as a call to action. She cautioned against men interpreting the data as reason to feel uniquely vulnerable. Instead, she positioned the numbers as an invitation for researchers to investigate the mechanisms driving these differences and to harness that understanding in the ongoing fight against the pandemic.

The researchers considered whether pre-existing health conditions might explain the gap. Men do tend to carry higher rates of certain chronic illnesses, but Webb and her team concluded that these differences alone could not account for the severity disparity they observed. The answer, they suggested, lay deeper in biology itself. Men, as a general population, mount weaker immune responses to many types of infections—a well-documented phenomenon in immunology. This inherent vulnerability appeared to be playing a significant role in how severely COVID-19 affected them once contracted.

One possibility the researchers raised was that men might actually be overrepresented in the confirmed case counts not because they were more likely to catch the virus, but because they were more likely to develop noticeable symptoms and progress to serious illness. This would make them more likely to seek testing and receive clinical care, skewing the apparent infection ratio. The data suggested that what looked like a sex difference in infection rates might actually reflect a difference in how the disease manifested and was detected.

The implications extended beyond epidemiology into public health strategy. The researchers argued that sex and gender should be treated as significant biological variables when designing new therapies and vaccination campaigns. A one-size-fits-all approach to COVID-19 treatment and prevention, they suggested, would miss an opportunity to account for these documented vulnerabilities and potentially tailor interventions accordingly. As the pandemic continued to evolve and vaccines rolled out globally, understanding these biological differences would become increasingly relevant to how health systems allocated resources and how individuals assessed their own risk.